Table 3.
The table describes ranking of the 16 core items by scleroderma experts and results of the cluster analysis
| Core item | Rank 1 (%) | Rank 2 (%) | Rank 3 (%) | Cluster |
|---|---|---|---|---|
| MRSS | 374 (44.1%) | 131 (15.5%) | 75 (8.9%) | 1 |
| FVC% predicted |
123 (14.5%) | 148 (17.5%) | 72 (8.5%) | 1 |
| Physician global assessment |
77 (9.1%) | 116 (13.7%) | 88 (10.4%) | 1 |
| Patient global assessment |
93 (11%) | 69 (8.2%) | 115 (13.6%) | 1 |
| HAQ-DI | 68 (8%) | 112 (13.2%) | 99 (11.7%) | 1 |
| Vitality SF-36 | 12 (1.4%) | 37 (4.4%) | 101 (11.9%) | 2 |
| GI VAS | 25 (2.9%) | 44 (5.2%) | 43 (5.1%) | 2 |
| Pain | 11 (1.3%) | 38 (4.5%) | 82 (9.7%) | 2 |
| Tendon friction rubs |
11 (1.3%) | 33 (3.9%) | 23 (2.7%) | 2 |
| Breathing VAS |
13 (1.5%) | 25 (3%) | 32 (3.8%) | 2 |
| Digital ulcers VAS |
7 (0.8%) | 38 (4.5%) | 17 (2%) | 2 |
| Raynaud’s VAS |
11 (1.3%) | 18 (2.1%) | 43 (5.1%) | 2 |
| Patient skin interference last month |
2 (0.2%) | 21 (2.5%) | 22 (2.6%) | 2 |
| Number of digital ulcers |
9 (1.1%) | 11 (1.3%) | 17 (2%) | 2 |
| Presence of renal crisis |
11 (1.3%) | 3 (0.4%) | 2 (0.2%) | 2 |
| Body mass index |
1 (0.1%) | 3 (0.4%) | 15 (1.8%) | 2 |
MRSS= modified Rodnan skin score, FVC= Forced vital capacity, HAQ-DI= health assessment questionnaire-disability index, GI= gastrointestinal, VAS= visual analog scale, MRSS= modified Rodnan skin score